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Crousillac S, Colonna J, McMains E, Dewey JS, Gleason E. Sphingosine-1-phosphate elicits receptor-dependent calcium signaling in retinal amacrine cells. J Neurophysiol 102: 3295–3309, 2009. First published
September 23, 2009; doi:10.1152/jn.00119.2009. Evidence is emerging
indicating that sphingosine-1-phosphate (S1P) participates in signaling in
the retina. To determine whether S1P might be involved in signaling in
the inner retina specifically, we examine the effects of this sphingolipid
on cultured retinal amacrine cells. Whole cell voltage-clamp recordings
reveal that S1P activates a cation current that is dependent on signaling
through Gi and phospholipase C. These observations are consistent with
the involvement of members of the S1P receptor family of G-proteincoupled receptors in the production of the current. Immunocytochemistry
and PCR amplification provide evidence for the expression of S1P1R and
S1P3R in amacrine cells. The receptor-mediated channel activity is
shown to be highly sensitive to blockade by lanthanides consistent with
the behavior of transient receptor potential canonical (TRPC) channels.
PCR products amplified from amacrine cells reveal that TRPCs 1 and 3–7
channel subunits have the potential to be expressed. Because TRPC
channels provide a Ca2⫹ entry pathway, we asked whether S1P caused
cytosolic Ca2⫹ elevations in amacrine cells. We show that S1Pdependent Ca2⫹ elevations do occur in these cells and that they might be
mediated by S1P1R and S1P3R. The Ca2⫹ elevations are partially due to
release from internal stores, but the largest contribution is from influx
across the plasma membrane. The effect of inhibition of sphingosine
kinase suggests that the production of cytosolic S1P underlies the sustained nature of the Ca2⫹ elevations. Elucidation of the downstream
effects of these signals will provide clues to the role of S1P in regulating
inner retinal function.

INTRODUCTION

Sphingosine-1-phosphate (S1P) is a sphingosine metabolite
that has been linked to numerous cellular functions, including
cell signaling, growth, differentiation, and programmed cell
death. S1P has also been implicated in neuronal signaling with
effects ranging from regulation of neural stem cell proliferation
(Harada et al. 2004) and migration (Kimura et al. 2007) to
calcium signaling (Giussani et al. 2007; Pollock et al. 2002),
increases in excitability (Zhang et al. 2006a,b), and exocytosis
(Kajimoto et al. 2007).
S1P is produced through phosphorylation of sphingosine by
sphingosine kinase (SphK) (Ghosh et al. 1994; Olivera et al.
1996). There are two forms of SphK (SphK1 and 2); however,
most is known about SphK1. SphK1 contains numerous phosphorylation sites and calcium/calmodulin binding sites, suggesting that SphK1 is regulated both by phosphorylation and
intracellular Ca2⫹ (Hla et al. 1999). Although the synthesis of
S1P is well understood, the mechanism underlying its release is
Address for reprint requests and other correspondence: E. Gleason, Dept. of
Biological Sciences, Louisiana State University, Baton Rouge, LA 70803
(E-mail: egleaso@lsu.edu).
www.jn.org

currently unresolved. It is known that S1P is not released via
exocytosis, but there is some evidence that release might occur
on an ATP binding cassette transporter (for review, see Kim
et al. 2009).
S1P has the potential to act both extracellularly via cell
surface receptors and intracellularly as a second messenger
(Van Brocklyn et al. 1998). Originally believed to function
solely as an intracellular second messenger linked to cell
proliferation and survival, it is now well-established that S1P is
the endogenous ligand for a family of G-protein-coupled cell
surface receptors referred to as S1P receptors (S1PRs). Currently five members of this family (S1P1R–S1P5R) have been
identified (see Kluk and Hla 2002 for review). S1P4R, however, has a low affinity for S1P and may have a different
endogenous agonist (Candelore et al. 2002).
S1P1R is thought to couple exclusively to the heterotrimeric
G protein Gi (Ancellin and Hla 1999; Lee et al. 1998; Windh
et al. 1999), consistent with the observation that S1P elicits
Ca2⫹ elevations through a pertussis toxin (PTX)-sensitive (and
therefore Gi-dependent) pathway in numerous cell types (An
et al. 1999; Ancellin and Hla 1999; Kon et al. 1999; Lee O et
al. 1999; Okamoto et al. 1998, 1999; Van Brocklyn et al. 1998;
van Coppen et al. 1996). Activation of S1P1R results in
inhibition of adenylyl cyclase (Zondag et al. 1998), activation
of phospholipase C (Okamoto et al. 1998), and mobilization of
intracellular Ca2⫹ through IP3-sensitive (Formigli et al. 2002;
Zhou and Murthy 2004) and IP3-insensitive Ca2⫹ stores
(Ghosh et al. 1994; Mattie et al. 1994; Meyer zu Heringdorf et
al. 1998; Tornquist et al. 1997).
S1P2R and S1P3R can couple to Gi, Gq, and G13 (Ancellin
and Hla 1999; Ishii et al. 2001; Kon et al. 1999; Okamoto et al.
1999; Sato et al. 1999; Windh et al. 1999; for review, see
Sanchez and Hla 2004). Consistent with this promiscuity,
activation of these receptors has been linked to both stimulation (Sato et al. 1999) and inhibition of adenylyl cyclase
(Okamoto et al. 1999) and stimulation of phospolipase C (An
et al. 1999; Ancellin and Hla 1999; Ishii et al. 2001; Okamoto
et al. 1999; Sato et al. 1999). There is also evidence for
preferential coupling with S1P2R coupling most strongly to
G13 and S1P3R most strongly activating Gq and subsequent
Ca2⫹ mobilization (Ishii et al. 2002). Less is known about
S1P5R, but signaling through Gi and G12 has been reported (Im
et al. 2005; Jaillard et al. 2005; Malek et al. 2001; Novgorodov
et al. 2007).
In addition to receptor-mediated pathways, sphingosine derivatives can also act intracellularly. Sphinganine-1-phosphate,
which is structurally similar to S1P, activates the entire family
of S1P receptors yet does not completely mimic the effects of
S1P (Van Brocklyn et al. 1998; Xia et al. 1998), suggesting
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additional sites of action for S1P. Also S1P mobilization of
intracellular Ca2⫹ has been observed independent of S1PR
expression (Van Brocklyn et al. 1998). Furthermore, effects on
proliferation and survival can be achieved through microinjection of S1P as well as through release of intracellular caged
S1P; providing further evidence for an intracellular interaction
site for S1P (Meyer zu Heringdorf et al. 2003a; Van Brocklyn
et al. 1998; Xia et al. 1998).
Very little is known about the signaling capabilities of
S1P in the vertebrate retina, but a few of its functions are
emerging. S1P can mediate the pathological process of
neovascularization that follows retinal injury (Skoura et al.
2007; Xie et al. 2009). There are also recent reports that S1P
functions during retinal development. S1P can regulate the
proliferation and differentiation of photoreceptors in rat
retinal cultures (Miranda et al. 2009) and can also be involved in axonal path-finding by retinal ganglion cells
(Strochlic et al. 2008). In amacrine cells, it has been demonstrated that S1P promotes transient Ca2⫹ influx events by
a receptor-independent mechanism in store-depleted dendrites (Borges et al. 2008). This indication that S1P can be
involved in Ca2⫹ signaling in amacrine cells has led us to
ask whether S1P receptor-dependent Ca2⫹ signaling might
also occur in these cells.
Amacrine cells are interneurons that participate in complex
synaptic interactions in the inner plexiform layer of the retina.
Synaptic input and output is not typically segregated in these
cells. Instead pre- and postsynaptic sites are intermingled on
amacrine cell dendrites. This arrangement implies that signaling between an amacrine cell and its synaptic partners (bipolar,
ganglion, and other amacrine cells) is highly localized. Consistent with this, localized Ca2⫹ signals have been demonstrated in amacrine cell dendrites both in the intact retina (Denk
and Detweiler 1999; Euler et al. 2002) and in culture (Azuma
et al. 2004; Hurtado et al. 2002; Medler and Gleason 2002; Sen
et al. 2007). Furthermore local and reciprocal signaling has
been established for an inhibitory feedback synapse between
amacrine and bipolar cells (Chavez et al. 2006; Vigh and von
Gersdorff 2005). This theme of local signaling might also be
extended to S1P. Thus far, the only evidence for production of
S1P in the inner retina is in amacrine cells (Borges et al. 2008),
but given its effects on photoreceptors (Miranda et al. 2009)
TABLE

1.

and ganglion cells (Strochlic et al. 2008), it is likely to be
produced elsewhere as well. Nonetheless it is well established
that many cells that synthesize and release S1P also respond to
it (for review, see Maceyka et al. 2008).
To further elucidate the signaling role for S1P in retinal amacrine cells, we have examined the effects of S1P on amacrine cells
cultured from the chick retina. Here we use a combination of
electrophysiology, immunocytochemistry, Ca2⫹ imaging, and
molecular biology methods to explore the signaling properties of
S1P in these retinal neurons. We demonstrate that S1P activates a
receptor-dependent current as well as cytosolic Ca2⫹ elevations.
Evidence is presented suggesting that the channels carrying the
S1P-dependent current might be transient receptor potential canonical (TRPC) channels. The signaling pathways that underlie
the current and the Ca2⫹ elevations appear to be complex and
interacting. Intriguingly, we find that synthesis of internal S1P
might also contribute to the response.
METHODS

Cell culture
Dissociation and culture methods have been previously reported (Hoffpauir et al. 2006). Briefly, retinas from 8-day-old White Leghorn chicken
embryos (Gallus gallus domesticus, Animal Sciences Department, Louisiana State University) were dissociated in 0.1% trypsin and plated at
5.0 ⫻ 105 cells/35-mm polyornithine-coated (0.1 mg/ml) tissue culture
dish. Cells were also plated onto polyornithine-coated glass coverslips for
immunocytochemistry. Retinal cultures were maintained in Neurobasal
(Invitrogen, Carlsbad, CA) supplemented with B27 (Invitrogen), 1,000 U
penicillin/ml, 100 g streptomycin/ml, and 1 mM L-glutamine (Sigma,
St. Louis MO).

Immunocytochemistry
Cells were fixed in 1% paraformaldehyde for 1 h at 4°C. Rabbit
polyclonal antibodies raised against sphingosine kinase 1 were purchased
from Abgent (San Diego, CA) but produced no labeling in either chicken
retinal tissue or cultured cells. Rabbit polyclonal antibodies raised against
human S1P1R and S1P3R were purchased from Cayman Chemical (Ann
Arbor, MI). Cultures were incubated for 1 h in 5% normal goat serum in
dilution solution [1% bovine serum albumin (BSA); 0.1% saponin in
PBS]. Anti-S1P1R and S1P3R antibodies were diluted in dilution solution to 1:500 and 1:250, respectively. Cells were incubated in primary
antibodies for 1 h at room temperature. After washing, Cy3-conjugated

Primer sequences for PCR amplifications

Primer

Sequence

Expected Product Size, bp

Annealing Temperatures

TRPC1 forward
TRPC1 reverse
TRPC3 forward
TRPC3 reverse
TRPC4 forward
TRPC4 reverse
TRPC5 forward
TRPC5 reverse
TRPC6 forward
TRPC6 reverse
TRPC7 forward
TRPC7 reverse
SphK1 forward
SphK1 reverse
S1P3R forward
S1P3R reverse

5⬘-GGTATTTTCTGTGAGAAG-3⬘
5⬘-CTTCTGATAATTCTCGTC-3⬘
5⬘-TCCTATGACGAAGACGGC-3⬘
5⬘-ACAGTTTGGATGAGCCAC-3⬘
5⬘-GCTGCTCCTAAGTTTTAATG-3⬘
5⬘-CCAGTTTCAATCTTGCAAG-3⬘
5⬘-CGCTTTGGTATGACGGTTTT-3⬘
5⬘-CCGGTGTGGCAGATAAACTT-3⬘
5⬘-GATGAAGATGGAACACGG-3⬘
5⬘-GCACTTTGGATGTGCTAC-3⬘
5⬘-GAGCTCCTCCTCAAAAAGG-3⬘
5⬘-CTAGTCTGGCCAATTCATTG-3⬘
5⬘-GAACCATACCACCCATCAG-3⬘
5⬘-TGCAGTTGGTCAGCAGTTTC-3⬘
5⬘-GCCATTCTGGTAGCCATTGT-3⬘
5⬘-TGACCAACAGGCAATGAAGA-3⬘

483

Ramped from 37–45° C, 1° C/30 sec.

600

48°C

618

44°C

178

48°C

450

45°C

476

47°C

221

54°C

156

53°C

TRPC, transient receptor potential canonical; SphK, sphingosine kinase; S1P, sphingosine-1-phosphate.
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goat anti-rabbit secondary antibodies (Invitrogen) were diluted to 1:1,000
and applied for 1 h at room temperature. Coverslips were mounted in
Vectashield (Vector Labs, Burlingame, CA) and viewed under fluorescent optics on an Olympus IX-70 inverted microscope. Digital images
were captured using IPLab (Bonn, Germany) version 4.0. Adobe Photoshop 7.0 was used to assemble the figures.
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tion. All methods involving animals were conducted in accord with
the National Institutes of Health guidelines and with approval of
the Louisiana State University Institutional Animal Care and Use
Committee. Whole cell lysates of chicken and rat brains were
homogenized in IP buffer (1% Triton X-100, 150 mM NaCl, 10
mM Tris pH7.4, 1 mM EDTA, 1 mM EGTA, 0.5% NP40) with a
protease inhibitor cocktail (Roche, Indianapolis, IN). Protein content was then quantified using the BioRad (Hercules, CA) protein
assay kit. Rat brain homogenate (150 g) and 50 g chicken brain
homogenates were loaded onto a 7.5% SDS-PAGE gel. Following
electrophoresis, proteins were transferred to nitrocellulose membranes. The membranes were then incubated overnight at 4°C with
blocking buffer (1% bovine serum albumin, 0.1% Tween 20, and
2% nonfat dry milk in Tris-buffered saline). Membranes were incubated

Western blots
Western blot analyses were conducted following the method described in Crousillac et al. (2003). Briefly, tissues for Western blots
were obtained from Sprague-Dawley rats (Laboratory Animal Medicine, LSU) killed by decapitation and White Leghorn chickens (Animal Sciences, LSU) killed by CO2 exposure followed by decapita-

A
Control

0 pA

10 pA

-20 pA

1 sec

1 µM S1P
0 pA
FIG. 1. Sphingosine-1-phosphate (S1P) elicits a cation
current. A, top: a representative amacrine cell is voltageclamped in the perforated-patch configuration at ⫺70 mV
and a control record is obtained. Middle: S1P (1 M) is
applied and a small inward current is elicited. A region of
the activated current is shown on an expanded time scale
(inset). Bottom: in a recording from another amacrine cell,
10 M S1P is applied, and after ⬃10 s, a noisy inward
current begins to develop. B: a voltage ramp is delivered and
an S1P-dependent current (leak-subtracted) is measured that
reverses at ⫹8 mV, suggesting that the current is carried by
a mixture of cations. S1P-dependent currents were also
recorded during a series of voltage steps (⫺70 to ⫹40 mV).
Currents recorded in a representative cell from 6 of those
steps are shown in C. Outward currents were not observed
unless the voltage was stepped positive to 10 mV (n ⫽ 4).
Currents have been offset vertically for clarity.

-20 pA

10 µM S1P
0 pA

25 pA

-20 pA

10 sec

B

C
Current (pA)

80

20 mV
40

10 mV
20

0 mV

-20

20
-20

40

60

-10 mV

Voltage (mV)

-20 mV

-40

40 pA

-40

30 mV

60

500 msec
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grated DNA Technologies (Coralville, IA). Messenger RNA isolation
was performed using Dynabeads mRNA DIRECT micro kit (Invitrogen,)
following the manufacturer’s isolation protocol. RT-PCR was conducted
using SuperScript III one-step RT-PCR with platinum Taq (Invitrogen) in
a PTC-100 thermal cycler (MJ Research, Waltham, MA). See Table 1 for
annealing temperatures. Forty cycles were run for each PCR. Actin was
used as a positive control and an RT(⫺) sample was used as a negative
control. Samples were then analyzed using 1.5% agarose gel electrophoresis (85 V for 1.25 h) in 0.5⫻ TBE buffer.
PCR products were purified using a ChargeSwitch PCR clean-up
kit (Invitrogen) then combined with Big Dye 3.1, ABI buffer, and
respective primers. Cycle sequencing was performed in a PTC-100
thermal cycler. EtOH dye terminator removal was conducted prior
to sequencing. Samples were then re-suspended in formamide and
sequenced using a 3130XL genetic analyzer (Applied Biosystems,
Foster City, CA). For all work reported here, PCR product sequences corresponded to regions of the predicted coding transcripts for the individual proteins as determined by BLAST queries.

in S1PR1 antibody (1:1,000, Cayman Chemical) at room temperature for
1 h and then incubated with a goat anti-rabbit IgG peroxidase conjugate
secondary antibody (1:5,000) for 1h at room temperature. The ECL
Western blotting detection reagent kit (Amersham, Piscataway, NJ) was
used for visualization of the antibodies.

PCR amplification
Retinal amacrine cells were harvested after 7 days in culture. These
cells have been previously characterized and can be identified based on
morphological criteria (Gleason et al. 1993). Ten to 20 amacrine cells
were collected into patch pipettes. The pipette tip was immediately
broken into a lysis buffer containing Tris-HCl, LiCl, EDTA, and LiDS.
The lysate was kept frozen at ⫺80°C until it was used for RT-PCR. A
basic local alignment search tool (BLAST) search revealed predicted G.
gallus gene sequences encoding TRPC protein subunits 1 and 3–7 as well
as S1P3R and SphK proteins. Gene-specific primers for transcripts encoding these proteins were designed using Primer3 (Rozen and Skaletsky
2000) and can be found in Table 1. Primers were obtained from Inte-

A

B

Untreated cell

PTX-Treated
Control

Control
0 pA

0 pA
1s

-25 pA

-25 pA

S1P

S1P

0 pA

0 pA

-25 pA
-50 pA

C

D
Control

Mean Charge Transfer

150

0 pA

120

1s

-25 pA

90

SEW 2871
0 pA

60

*

30

-50 pA

0

PTX-treated

E

Control

F

0 pA
1s
-25 pA

0 pA

Suramin / S1P

-25 pA

0 pA

S1P

600
500

Mean Charge Transfer

Untreated

FIG. 2. Activation of S1P1R and S1P3R may both contribute to the S1P-dependent current. A: an untreated cell
that is voltage-clamped at ⫺70 mV is exposed to S1P (10
M), and a noisy, inward current is observed (bottom
trace). B: cells were pretreated overnight (18 –22 h) with
pertussis toxin (PTX, 200 ng/ml). A PTX-treated cell that is
voltage-clamped at ⫺70 mV exhibits only a small inward
shift in baseline current in the presence of S1P. C: comparison of the S1P-dependent charge transfer between treated
(n ⫽ 21) and untreated cells (n ⫽ 17) revealed a significant
reduction in the responses of PTX-treated cells (P ⫽ 0.02).
D: SEW2871 (10 M), an S1P1R-selective agonist, also
elicits a noisy inward current. E: a cell is voltage clamped
at ⫺70 mV and exposed to suramin (100 M), an inhibitor
of S1P3R signaling. Suramin reversibly inhibits the S1Pdependent current (middle trace). F: analyses of S1Pdependent charge transfer reveals that suramin significantly
suppresses the current (n ⫽ 9, P ⫽ 0.003). C and F, error
bars are SE.

400
300
200

*

100
0

Untreated

Suramin-treated

-50 pA
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Electrophysiology
Culture dishes were mounted on the stage of an Olympus IX-70
inverted microscope and a Ag/Ag-Cl pellet served as a reference electrode in the culture dish. Data were acquired using an Axopatch-1D
amplifier, Digidata 1322 data-acquisition board, and pClamp 9.2 software
(Molecular Devices, Sunnyvale, CA). Unless otherwise noted, voltageclamp recordings were made in the perforated-patch configuration. Patch
pipettes were pulled from borosilicate glass (1.5 mm OD, 0.86 mm ID)
using a Flaming/Brown puller (Sutter Instruments, Novato, CA) and had
tip resistances of 3–5 M⍀. For perforated-patch experiments, amphotericin B stock was made at 40 g/ml in dimethyl sulfoxide (DMSO).
Amphotericin was combined 1:2 with Pluronic F-127 (Invitrogen, 25
mg/ml DMSO) and diluted in internal solution for a final amphotericin
concentration of 140 g/ml. Gigaohm seals were achieved with a brief
hyperpolarizing pulse of ⫺140 mV. Then unless otherwise indicated, the
voltage was clamped at ⫺70 mV. Voltage values were not corrected for
the (unknown) liquid junction potential resulting from the perforatedpatch configuration. Recordings were made at room temperature. All
current traces shown were leak-subtracted. For experiments in which
charge transfers were compared, data from the same time frame were
analyzed for each condition, and the mean charge transfer was calculated
for five second windows of time.

Fluorescence measurements
Oregon Green bis-(o-aminophenoxy)-N,N,N’,N’-tetraacetic acid
(BAPTA) 488 was prepared as a 2 mM stock solution in DMSO,
combined 1:1 with Pluronic F127 (Invitrogen, 25 mg/ml DMSO), then
diluted to 2 M in Hank’s balanced salt solution (Invitrogen). Cells
were loaded for 1 h at room temperature in the dark. Cells were then
washed with external solution and kept in the dark until the beginning
of the experiment, typically ⬃20 min. Culture dishes were mounted

A

C

Control

0 pA
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on the stage of an Olympus IX-70 inverted microscope, and images
were acquired using IP Lab image capturing software version 4.0.
Shutter interval for imaging experiments was 1 s (2 s for Fig. 11B),
and exposure time was 150 ms. Fluorescence intensity data were
collected from amacrine cell bodies. Background fluorescence was
subtracted from all data. For display, raw fluorescence intensity values
were normalized to baseline values and are reported as F/Fo.

Solutions and reagents
Reagents were purchased from Sigma unless otherwise indicated.
Normal external solution consisted of the following (in mM): 5.3 KCl,
136.9 NaCl, 3.0 CaCl2, 0.4 MgCl2, 3.0 HEPES, and 5.6 glucose.
Tetraethylammonium (TEA) external solution consisted of the following (in mM) 5.3 KCl, 116.7 NaCl, 20.0 TEA Cl, 3.0 CaCl2, 0.4
MgCl2, 5.6 glucose, and 10.0 HEPES. For electrophysiology, external
solutions also contained bicuculline methiodide (3.0 M) to block
GABAergic synaptic currents and TTX (300 nM) to block voltagegated Na⫹ channels. Cesium internal solution (for ruptured patch)
consisted of the following: 100.0 Cs acetate, 10.0 CsCl, 0.1 CaCl2, 2.0
MgCl2, 10.0 HEPES, and 1.1 EGTA. Internal B solution (for perforated patch) consisted of the following: 135 Cs acetate, 10.0 CsCl, 2.0
MgCl2, 0.1 CaCl2, 1.1 EGTA, 10.0 HEPES, and 1.0 NaCl.
S1P (Biomol, Plymouth Meeting, PA) was prepared as a 1 mM
stock in methanol then diluted in external solution to a final concentration of either 1 or 10 M. The PLC inhibitor U73122 and its less
active analog U73343 were used at 10 M and purchased from
Biomol. The IP3 receptor antagonist heparin (Calbiochem, San Diego,
CA) was included in the patch pipette at a final concentration of 5
mg/ml. The S1P1R selective agonist SEW2871 was purchased from
Cayman Chemical (Ann Arbor, MI) and prepared as a 10 mM stock
in DMSO. PTX (Calbiochem) was used at a final concentration of 200
ng/ml. Cells were incubated for 18 h in PTX diluted in culture

Control

0 pA
1s

-25pA

S1P / U73122

S1P/ U73343

0 pA

0 pA

-25pA
-50 pA

S1P

S1P
0 pA

0 pA

-50 pA

-50 pA

D

Mean Charge Transfer

500
400
300
200
100

*

0

500

Mean Charge Transfer

B

FIG. 3. The S1P-induced current is phospholipase C
(PLC)-dependent. A: a representative amacrine cell is voltageclamped at ⫺70 mV. S1P (10 M) was applied in the
presence of the PLC inhibitor U73122 (10 M, middle trace).
After 1 min, the U73122 was removed (bottom trace). B: the
mean charge transfer was significantly reduced by the inhibitor
(n ⫽ 6, P ⫽ 0.02). C: a separate cell is voltage-clamped at
⫺70 mV and then exposed to S1P in the presence of U73343
(10 M), a less active analogue of U73122. The analogue did
not suppress the S1P current. D: the mean charge transfer was
unaffected by U73343 (n ⫽ 6, P ⫽ 0.98). B and D, error bars
are SE.

400
300
200
100
0

S1P

U73122-S1P

S1P
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medium. Following the incubation period, cells were washed in
normal solution and used immediately for electrophysiology experiments. PTX-treated cells used for Ca2⫹-imaging experiments were
washed in normal external solution and loaded with the dye for 1 h
prior to recording. Suramin was dissolved directly in the external
solution at a concentration of 100 M. N,N-dimethyl-D-erythrosphingosine (DMS, Biomol) was diluted in ethanol at a concentration
of 10 mM then diluted into external solution at a final concentration
of 10 M.

Data analysis
Statistical significance was evaluated using the Student’s t-test. The
data in Figs. 2E and 3, B and D, were evaluated using the paired form
of the test. Error bars represent SE.

the S1P-dependent current could be elicited with 1 M S1P,
the higher concentration was used for most of the experiments
because the responses to 10 M S1P had a faster onset and
were more easily distinguishable. To determine the ionic composition of the S1P-dependent current, voltage ramps were
delivered during S1P-dependent current activation to reveal its
reversal potential (Fig. 1B). On average, the current reversed at
7.8 ⫾ 8.5 mV (n ⫽ 11). The noisy nature of the S1P-dependent
current made it difficult to accurately measure its reversal
potential and likely contributes to the variability in the values.
However, using voltage steps, we found that outward current
could only be observed when the voltage was stepped to
positive values (Fig. 1C, n ⫽ 4) suggesting that the S1Pdependent current is carried by a mixture of cations.

RESULTS

Individual amacrine cells were voltage-clamped at ⫺70 mV.
S1P (1 or 10 M) elicited a noisy inward current that developed after ⬃10 s of exposure (Fig. 1A). Once activated, the
current usually persisted after the removal of agonist. Although

S1P-dependent current may involve signaling through S1P1R
and S1P3R
Because S1P signals through G-protein-coupled receptors and
most commonly through Gi, cells were incubated overnight in

FIG. 4. S1P receptors are expressed by amacrine cells.
A: S1P1R is thought to couple to Gi exclusively, whereas
S1P3R can couple to Gi, Gq, or G13. Signaling through these G
proteins converges at the level of PLC activation. B: Western
blot analysis of the S1P1R antibody reveals a single band
present for both chicken and rat brain homogenates just below
the 50-kDa marker, consistent with the predicted molecular
weight for the S1P1R (47 kDa). C: secondary-only controls did
not show any nonspecific labeling in cultured cells. D: the
S1P1R antibody labels all amacrine cell bodies (arrows) and
their processes in culture. Cone photoreceptors label intensely
with this antibody (asterisks) and have been overexposed in
this image so that the amacrine cell labeling can be observed.
E: in a pattern similar to the S1P1R antibody, the S1P3R
antibody labels all amacrine cell bodies and their processes in
cell culture. All of the cells in this image are amacrine cells.
Scale bars are 25 m. F: S1P3R gene-specific primers were
use to amplify mRNA from ⬃15 amacrine cells collected from
a culture dish. The PCR product produced a single band of the
appropriate size (156 bp). The identity of the product as a
component of the transcript encoding S1P3R was confirmed
by sequence analysis.
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PTX (200 ng/ml), an inhibitor of Gi-mediated signaling. In untreated cells, S1P elicited the typical current (Fig. 2A). However,
in cells pretreated with PTX, the S1P current was reduced in
amplitude (Fig. 2B), suggesting that activation of Gi contributes to the S1P-induced current. Because the S1P-induced
current is so noisy, currents were integrated over 5-s windows
so that they could be quantified. Comparison of charge transfer
revealed a significant reduction in the S1P-dependent current in
PTX-treated cells (Fig. 2C). To determine whether the Gidependent receptor S1P1R was involved in the response, we
used SEW2871, a synthetic agonist selective for the S1P1R
receptor (Sanna et al. 2004). SEW2871 (10 M) elicited a
noisy inward current similar to the S1P-induced current
(Fig. 2D).
Because PTX treatment resulted in only partial inhibition of
the S1P-mediated current, we asked whether another receptor
was being activated by S1P. To explore this, we examined the
effects of suramin, a polycyclic anionic compound that can
disrupt the interactions between G proteins and G-proteincoupled receptors (Freissmuth et al. 1999). Especially relevant
here, however, is that suramin has been shown to inhibit the
S1P-dependent activation of S1P3R but does not interfere with
signaling via S1P1R or S1P2R (Ancellin and Hla 1999).
Suramin can also inhibit other receptors (Sim et al. 2008), but
it had no effect on the membrane current when applied alone
(not shown). In cells exposed to S1P in the presence of
suramin, the noisy inward current was reversibly reduced (Fig.
2E). Charge transfer analysis revealed a significant reduction in
the S1P-dependent current in the presence of suramin (Fig.
2F), suggesting that signaling through S1P3R contributes to
production of the S1P-dependent current. Note that the small
S1P-dependent inward shift in the baseline current persists in
the presence of either blocker (Fig. 2, B and E, middle trace).
Interestingly, PTX and suramin each inhibited the S1P-dependent current by ⬃75– 80%. This level of inhibition suggests a
synergistic relationship between two pathways, such that the
total current mediated by S1P and its receptors is greater than
the sum of the currents engendered by activation of a single
receptor.

3301

S1P1R antibody. Antibodies were incubated with a blot of
proteins from chicken brain and rat brain homogenates, respectively. A single band was present just below the 50-kDa marker
in both lanes (Fig. 4B) consistent with the predicted molecular
weight of S1P1R (47 kDa). For immunocytochemistry, secondary-only control experiments revealed no nonspecific binding of the secondary antibodies (Fig. 4C). S1P1R antibodies
labeled all amacrine cell bodies as well as their processes in
cell culture (Fig. 4D, arrows). Interestingly, another identified
cell type in these cultures, cone photoreceptors, showed very
strong anti-S1P1R labeling (Fig. 4D, asterisks), suggesting a
possible signaling role for S1P in the outer retina.
The antibody raised against S1P3R labeled all amacrine cells
in culture (Fig. 4E). Unfortunately we were not able to identify
a S1P3R band in Western blots of proteins from either chicken
or rat brain. As such, the labeling of amacrine cells is considered S1P3R-like. To support this labeling, we took an alternative approach of RT-PCR amplification of S1P3R mRNA
collected from a population of amacrine cells using genespecific primers (Fig. 4F). A 156-bp PCR product was amplified, which was consistent with the predicted product size. The
PCR product was sequenced to confirm its identity as a
component of the S1P3R coding transcript. These results are
consistent with the S1P3R-like antibody labeling and our
physiological results and suggest that amacrine cells express
both S1P1R and S1P3R. Nonetheless, complete confirmation
of the expression of S1P3R must await a demonstration that the
protein is expressed.
S1P-induced current is IP3 receptor-independent
Activation of phospholipase C results in the hydrolysis of
phosphatidylinositol 4,5 bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3), which then
typically activates IP3 receptors. To test the involvement of
IP3 receptors specifically, we included the IP3 receptor
antagonist heparin (5 g/ml) in the patch pipette and recorded from amacrine cells in the ruptured patch configu-

A

Control / Heparin

S1P-induced current is PLC-dependent
0 pA

The activation of either S1P1R or S1P3R can lead to
activation of PLC (Fig. 4A). To determine whether S1P is
activating the current through a PLC-dependent pathway, we
used the PLC inhibitor U73122 in voltage-clamp experiments.
The S1P-dependent current was measured in the presence of
U73122. The S1P-induced current was inhibited in the presence of U73122 (Fig. 3A), suggesting that the current is PLC
dependent. Charge transfer analysis indicated that U73122
caused a significant reduction in the S1P-dependent current
(Fig. 3B). In control experiments, the less active analog
U73343 was applied along with S1P and had no effect on the
S1P-dependent current (Fig. 3, C and D).
S1P receptor expression
Because we had physiological evidence that S1P1R and
S1P3R might be involved in the S1P response, the binding of
polyclonal antibodies raised to these receptors was examined.
Western blot analysis was used to confirm the specificity of the
J Neurophysiol • VOL
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B
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FIG. 5. The S1P current is IP3 receptor-independent. A: the IP3 receptor
blocker heparin (5 g/ml) was included in the patch pipette for ruptured-patch
voltage-clamp recordings. Before S1P application, the holding current in the
heparin-perfused cells was similar to that seen in perforated patch recordings.
In S1P, noisy currents develop that are similar in amplitude and appearance to
S1P-induced currents recorded in the perforated-patch configuration.
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FIG. 6. The S1P-dependent current is lanthanide-sensitive. A and B, top traces: 2 separate cells are voltageclamped at ⫺70 mV in the perforated-patch configuration.
S1P activates a noisy inward current (middle traces). Most
of the S1P-dependent current is eliminated in the presence
of either La3⫹ (10 M) or Gd3⫹ (10 M, bottom traces).
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ration. The S1P-induced current was not blocked by the
inclusion of heparin in the recording pipette (n ⫽ 7; Fig. 5),
even after ⬎20 min of recording time (post-rupture, Fig.
5B), suggesting that the current activation is independent of
IP3 receptor activation.
S1P-induced current is lanthanide-sensitive
In considering the possible mediators of the S1P-dependent
current, we were able to rule out activation of GABAA receptors because the Erev for the S1P-dependent current was too
positive (ECl- ⫽ ⫺58 mV) and because external recording
solutions contained bicuculline methiodide to block these receptors. Cyclic-nucleotide-gated channels were also ruled out
because 8 Br-cAMP and 8 Br-cGMP do not elicit a current in
amacrine cells (Sosa et al. 2002; B. K. Hoffpauir and E.
Gleason unpublished observations). We were also able to rule
out activation of L-type voltage-gated Ca2⫹ channels based on
three considerations. First, the voltage was clamped at ⫺70
mV, well outside the activation range of these L-type voltagegated Ca2⫹ channels (approximately ⫺40 mV). Second, nifedipine (10 m) was routinely included in external recording
solutions to block L-type Ca2⫹ channels. And third, the Erev for
the S1P-dependent current was not positive enough to represent Ca2⫹ flux alone. As nonselective cation channels linked to
G-protein-coupled receptor activation, TRPC channels were
good candidates for the mediators of this current. TRPC
channels are sensitive to low micromolar concentrations of the
lanthanides La3⫹ and Gd3⫹. To address the possibility that

3+

TRPC channels mediate the S1P-induced current, we examined
the effects of La3⫹ (10 m) and Gd3⫹ (10 m) on the S1P (10
M) current. Both La3⫹ (Fig. 6A) and Gd3⫹ (B) consistently
inhibited the S1P current. Note that with lanthanides, as for the
G protein inhibitors and PLC inhibitor, a sustained S1Pdependent current persists. Although the origin of this current
component is not known, its resistance to all of these agents
suggests that it might be due to a direct, nonreceptor-mediated
effect of S1P. As for the larger component of the current,
however, its regulation, selectivity, and lanthanide sensitivity
are all consistent with the possibility that it is mediated by
TRPC channels.
TRPC transcripts are present in cultured amacrine cells
To address the possibility that TRPC channels are involved
in the S1P-induced current, gene-specific primers were designed for TRPC subunits 1 and 3–7 using predicted sequences
in the chicken genome. PCR-amplification of TRPC subunits
was performed on small populations (10 –20) of amacrine cells
collected in a patch pipette. Amplifications produced bands at
the appropriate molecular weights (Fig. 7 and Table 1). Individual TRPC subunit PCR product identity was confirmed by
sequencing. Because we used mRNA isolated from multiple
amacrine cells in our amplifications, we cannot resolve
whether an individual amacrine cell can express all of the
subunits.

FIG. 7. Transient receptor potential canonical (TRPC)
subunit mRNAs are expressed in cultured amacrine cells.
A: gene-specific primers were designed against TRPC subunits 1 and 3–7. Transcripts were PCR-amplified from 10 to
20 amacrine cells collected in patch pipettes. All of these
PCR products were run on the same gel. Expected sizes of
the PCR products are in Table 1. Actin was amplified as a
positive control.
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S1P causes a cytosolic Ca2⫹ increase

exposure to S1P, sometimes for minutes (Fig. 8C, inset). To
examine the source of the Ca2⫹ increase, Ca2⫹ imaging experiments were repeated in the absence of external Ca2⫹. In
0-Ca2⫹, S1P elicited small Ca2⫹ increases that were presumably due to release of Ca2⫹ from internal stores (Fig. 8D).
When external Ca2⫹ was re-introduced, substantial cytosolic
Ca2⫹ increases were observed, further supporting the idea that
S1P stimulates Ca2⫹ entry across the plasma membrane.
To examine the temporal relationship between the S1Pdependent Ca2⫹ elevations and the S1P-dependent current,
simultaneous Ca2⫹-imaging and voltage-clamp experiments
were done. Amacrine cells were preloaded with Oregon Green
BAPTA 488 AM then voltage-clamped in the perforated-patch

One of the primary functions of TRPC channels is to
mediate Ca2⫹ influx. Thus if TRPC channels (or other nonselective, Ca2⫹-permeable cation channels) are involved, S1P
should elicit Ca2⫹ elevations that are dependent on external
Ca2⫹. To determine the effects of S1P on cytosolic Ca2⫹,
Ca2⫹-imaging experiments were done on Oregon Green
BAPTA 488-loaded amacrine cells. Control data show that the
vehicles for S1P (methanol) and DMS (see following text,
ethanol) do not elicit a Ca2⫹ elevation (Fig. 8A). S1P at either
1 or 10 M produced La3⫹-sensitive increases in cytosolic
Ca2⫹ (B and C). In the absence of La3⫹, the time course of the
Ca2⫹ elevations was more variable and could outlast the
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FIG. 8. S1P generates La -sensitive Ca
elevations in
amacrine cells. Cells were loaded for 1 h with the Ca2⫹sensitive dye Oregon Green BAPTA 488. A: a representative example of a fluorescence recording testing the effects
of the vehicle for S1P (1% Met-OH) and N,N-dimethyl-Derythro-sphingosine (DMS, 1% Et-OH), a reagent used in
the experiments depicted in Fig. 11. No Ca2⫹ elevations
were seen in response to these compounds. B: a representative recording shows that 1 M S1P can elicit La3⫹sensitive Ca2⫹ elevations. C: data from a different cell
showing a La3⫹-sensitive cytosolic Ca2⫹ increase to 10 M
S1P. Inset: data from a different cell showing that in the
absence of La3⫹, the Ca2⫹ elevations can persist well after
the removal of S1P (scale bars are 1.1 F/F0 and 30 s). D: in
0-Ca2⫹, a small S1P-dependent Ca2⫹ increase was observed, likely representing release of Ca2⫹ from internal
stores. Re-introduction of external Ca2⫹ produced a dramatic increase in the S1P-dependent Ca2⫹ elevation. E: an
amacrine cell preloaded with Oregon Green Bapta 488 is
voltage-clamped at ⫺70 mV in the perforated-patch configuration. S1P causes a cytosolic Ca2⫹ increase that precedes the inward S1P-dependent current. F: in a different
cell, S1P-induces a cytosolic Ca2⫹ increase that occurs
simultaneously with the S1P-dependent current.
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were produced by subsequent exposure to S1P (Fig. 9C). The
remaining cells (16/46) had very small SEW responses in
comparison to the responses engendered by S1P. These small
SEW responses might be due to incomplete inhibition of Gi by
PTX. These results suggest that in control cells, SEW2871 is
eliciting Ca2⫹ elevations by activating S1P1R and Gi.
To test the possible involvement of S1P3R in the S1Pdependent Ca2⫹ elevations, we examined the effects of
suramin. Suramin alone had no effect on cytosolic Ca2⫹. S1P
in the presence of suramin, typically produced small elevations
in cytosolic Ca2⫹ (Fig. 9D, asterisk) relative to those elicited in
the same cell after suramin had been removed (D), suggesting
that a substantial fraction of the S1P-induced Ca2⫹ increases
occurs through activation of S1P3R.
Because our fluorescence measurements are nonquantitative,
we do not know whether S1P responses in cells pretreated with
PTX are smaller than those in untreated cells. To address
whether S1P-dependent Ca2⫹ elevations typically occurred by
signaling via both S1P1R and S1P3R, we examined the effects
of blocking signaling through both receptors. In 72% (n ⫽ 61)
of PTX- and suramin-treated cells, S1P had no effect on
cytosolic Ca2⫹ (Fig. 9E). The balance of the PTX-treated cells
had small but detectable Ca2⫹ increases in response to S1P in
the presence of suramin, again suggesting that the inhibition of

recording configuration. In some cells (5 of 13), S1P produced
cytosolic Ca2⫹ increases that preceded development of the
S1P-dependent current (Fig. 8E). In other cells, (8 of 13),
S1P-dependent Ca2⫹ elevations and the S1P-dependent current
had a similar onset (Fig. 8F). The S1P-induced membrane
current was never observed to precede elevations in cytosolic
Ca2⫹, suggesting that release of internal Ca2⫹ is a prerequisite
for the activation of the current.
S1P-induced Ca2⫹ increase is receptor-mediated
To further explore the link between the S1P-dependent Ca2⫹
elevation and the S1P-dependent current, we used PTX to inhibit
Gi-mediated signaling. In PTX-treated cells, S1P induced increases in cytosolic Ca2⫹ in 50 of 99 cells tested (Fig. 9A),
suggesting that the S1P-dependent Ca2⫹ increases could be
activated through a Gi-independent mechanism. However, in a
separate experiment, the S1P1R-selective agonist SEW2871
consistently produced Ca2⫹ elevations, indicating that activation of S1P1R alone was sufficient to elicit a Ca2⫹ increase
(Fig. 9B). If SEW2871 is activating S1P1R alone and S1P1R is
the primary receptor linked to Gi, then we would expect that
PTX pretreatment would inhibit SEW-dependent Ca2⫹ elevations. In 65% of PTX-treated cells examined (n ⫽ 46),
SEW2871 did not elicit Ca2⫹ elevations, but Ca2⫹ elevations
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FIG. 9. The S1P-induced cytosolic Ca
increase may be mediated by both S1P1R and S1P3R. A: cells were pretreated overnight (18 –22 h) in pertussis toxin
(200 ng/ml) to inhibit receptor signaling through Gi. A cell is loaded with Oregon Green BAPTA 488 and then exposed to S1P. S1P still induces a Ca2⫹ increase
despite the pretreatment with PTX. B: to determine if activation of S1P1R alone is sufficient to elicit a Ca2⫹ increase, SEW2871 (10 M) is applied. In the
presence of SEW2871, a small cytosolic Ca2⫹ increase is observed. C: in a representative PTX-treated cell, SEW2871 produces little or no Ca2⫹ elevation. S1P,
however, elicited a La3⫹-sensitive response. D: a cell is exposed to suramin (100 M) to inhibit signaling through S1P3R. In suramin and S1P, a small cytosolic
Ca2⫹ increase was observed (asterisk). When suramin was removed, the cell responded with a substantially larger Ca2⫹ increase. E: cells were pretreated
overnight in PTX and exposed to suramin to inhibit signaling through Gi and S1P3R. The majority of PTX-treated cells (27/44) showed no S1P-dependent Ca2⫹
increase in the presence of suramin.
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Gi by PTX might be incomplete. Alternatively, it is possible
that another receptor is involved or that there is a direct
(nonreceptor-mediated) effect of S1P as observed by Van
Brocklyn et al. (1998).
Activation of either S1P1R or S1P3R can elicit release of
Ca2⫹ from internal stores
To further investigate the source of the receptor-mediated
Ca2⫹ increases, cells were either incubated overnight in PTX
or exposed to suramin to inhibit signaling through Gi (S1P1R)
and S1P3R, respectively, and to isolate signaling through the
two receptors. Ca2⫹-free external solution was used to isolate
the source of the Ca2⫹ increase. In PTX-treated cells, S1P
resulted in either release of Ca2⫹ from internal stores, followed
by external Ca2⫹ influx, or Ca2⫹ influx without detectable
store release. Store release alone was never observed in PTXtreated cells (n ⫽ 70; Fig. 10, A and B). In suramin-treated
cells, S1P resulted in release of Ca2⫹ from stores, Ca2⫹ influx,
or in most cases a combination of both mechanisms (n ⫽ 69;
Fig. 10, C and D). These results suggest that S1P1R-mediated
Ca2⫹ elevations (suramin-treated) can result from either Ca2⫹
influx or store release or both. They also suggest that Ca2⫹
influx dominates S1P3R-dependent Ca2⫹ elevations (PTX pretreated) and that the responses via this receptor are not generated by store release alone.
Synthesis of S1P in amacrine cells
These studies provide multiple pieces of evidence for receptor-mediated S1P signaling in retinal amacrine cells. There is
physiological evidence suggesting that cultured amacrine cells
express the synthetic enzyme for S1P, sphingosine kinase
(SphK) (Borges et al. 2008). We attempted to use polyclonal
antibodies raised against SphK1 (see METHODS) but were un-
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successful with this approach. To further explore the expression of SphK in amacrine cells, we designed gene-specific
primers for SphK 1. A PCR product of the appropriate size was
amplified from mRNA isolated from a collection of 10 –20
amacrine cells. Sequencing confirmed that the PCR product
was from the mRNA encoding SphK 1, consistent with the
findings of Borges et al. (2008) and suggesting that it is
possible for the enzyme to be expressed in amacrine cells
(Fig. 11A).
Because SphK is Ca2⫹-calmodulin-sensitive (Alemany et al.
2000; Sutherland et al. 2006), it is possible that the receptormediated, S1P-dependent Ca2⫹ elevations lead to further production of internal S1P. To address the possibility that cytosolic S1P was being generated, we asked whether a competitive inhibitor of SphK, DMS (Edsall et al. 1998; Yatomi et al.
1996) would have any effect on the duration of S1P-dependent
Ca2⫹ elevations. DMS is reported to also inhibit protein kinase
C in vitro (Igarashi and Hakomori 1989), but this effect was
not observed in intact cells from three different cell lines
(Edsall et al. 1998). Additionally, results reported for human
neutrophils (Igataki and Hauser 2003) and cultured chick
amacrine cells (Borges et al. 2008) indicate that the target of
DMS is SphK rather than the influx channels themselves. It is
important to note here that in the absence of inhibition by
lanthanides, both the S1P-dependent current and the S1Pdependent Ca2⫹ elevations often persist after removal of the
agonist and that Ca2⫹ influx (as opposed to release from stores)
is the primary source of the Ca2⫹ elevation. Here we test the
hypothesis that the persistent nature of the response is due to
generation of cytosolic S1P subsequent to receptor activation.
Control cells (n ⫽ 19) were exposed to S1P for 30 s then
returned to normal external. After removal of S1P, Ca2⫹ levels
tended to remain elevated for the remainder of the recording
period (90 s, Fig. 11B, solid trace). We tested for the involve-
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FIG. 10. Activation of either receptor can elicit release
of Ca2⫹ from internal stores. A: an amacrine cell has been
pretreated with PTX. In this cell, no S1P-dependent Ca2⫹
elevation is observed in the absence of external Ca2⫹.
Re-introduction of extracellular Ca2⫹ results in a cytosolic
Ca2⫹ elevation. B: cells treated with PTX responded with
either release of Ca2⫹ from internal stores followed by
external Ca2⫹ influx, or Ca2⫹ influx without internal store
release (as in A, n ⫽ 70). C: data from an amacrine cell
exposed to suramin. In 0 external Ca2⫹, a small S1Pdependent calcium elevation is observed. Re-introduction of
extracellular Ca2⫹ increased the magnitude of the S1Pdependent Ca2⫹ elevation. D: cells in suramin responded to
S1P with either store release only, Ca2⫹ influx only, or most
often, a combination of both responses (n ⫽ 69).
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A

(-) Ctrl

ment of internal S1P in a separate set of cells (n ⫽ 19) by
applying DMS after washout of S1P. With DMS, cytosolic
Ca2⫹ levels typically declined more rapidly than in control
(Fig. 11B, dotted trace). Overall, DMS significantly accelerated
the recovery of the Ca2⫹ elevations (Fig. 11C, P ⫽ 0.0002).
This suggests that extracellular S1P binding to receptors might
lead to activation of SphK, synthesis of S1P, and a relatively
sustained activation of a Ca2⫹ influx pathway.
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FIG. 11. Inhibition of SphK limits the duration of the S1P-dependent Ca
elevations. A: SphK1 gene-specific primers were use to amplify mRNA from
⬃15 amacrine cells collected from a culture dish. The PCR product produced
a single band of the appropriate size (221 bp). The identity of the product as
SphK1 was confirmed by sequence analysis. B: control cells were exposed to
S1P for 30 s followed by 90 s in normal external. Normalized data from a
representative amacrine cell show that the cytosolic Ca2⫹ level does not
recover on this time frame (solid trace). However, when DMS (10 M) was
applied (time indicated by the bar, data from a different cell, dotted trace), a
decline in cytosolic Ca2⫹ was typically observed. C: averaged data are shown
from 19 control and 19 DMS-treated cells. To calculate the percent change,
raw fluorescence values were obtained for both groups at t ⫽ 120 s (the
onset of DMS application) and t ⫽ 150 s (when DMS was removed). Error
bars are SE.
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In this study, we demonstrate that S1P activates a receptormediated cation current in retinal amacrine cells. S1P-dependent currents have been observed in other cell types, including
human umbilical vein endothelial cells (Muraki et al. 2001).
This current is a PTX-sensitive, nonselective cation current
similar to what we have found in amacrine cells. It is wellestablished that S1P can induce increases in cytosolic Ca2⫹.
However, the source of the S1P-mediated Ca2⫹ increase varies
from one cell type to another. In Swiss 3T3 fibroblasts, Mattie
et al. (1994) observed a transient increase in intracellular Ca2⫹
in response to S1P. The Ca2⫹ increase was independent of
extracellular Ca2⫹ and was abolished when internal Ca2⫹
stores were depleted with thapsigargin. In contrast, Formigli
et al. (2002) demonstrated in myoblast cells that S1P elicits a
transient Ca2⫹ increase propagating as a wave throughout the
cell and that the Ca2⫹ increase required both intra- and extracellular Ca2⫹ mobilization. Here in amacrine cells, S1P elicits
a cytosolic Ca2⫹ increase that is dominated by Ca2⫹ influx but
also involves release of Ca2⫹ from internal stores. The influx
pathway, however, appears to be different for myoblasts and
amacrine cells. In myoblast cells, the S1P-mediated Ca2⫹
response was significantly reduced through pretreatment of
cells with the L-type calcium channel blocker nifedipine (Formigli et al. 2002), indicating the involvement of these voltagedependent Ca2⫹ channels. In the current study, however, we
rule out the involvement of these channels on several criteria.
Thus S1P is capable of activating an inward cation current in
amacrine cells independent of voltage-gated ion channel activation.
Our data suggest that the S1P-dependent current and Ca2⫹
influx are initiated by activation of both S1P1R and S1P3R in
amacrine cells. For S1P1R, this suggestion is supported in part
by antibody labeling. Although there can be specificity problems with antibodies against G-protein-coupled receptors
(Michel et al. 2009), the ability of SEW2871 to activate both
the current and Ca2⫹ influx at a concentration demonstrated to
be ineffective on the other S1P receptors (Sanna et al. 2004)
tempers this concern.
The evidence for the expression of S1P3R in amacrine cells
is somewhat more tenuous. We have amplified a PCR product
from amacrine cell mRNA that corresponds to a coding region
of the S1P3R gene, and we observe S1P3R-like immunoreactivity but we are not able to confirm the expression of the
protein. Several of our physiological results, however, suggest
that this receptor is expressed in amacrine cells. First, we find
that suramin is an effective inhibitor of S1P-dependent current
and Ca2⫹ influx. The effects of suramin must be interpreted
with caution because it can have wide ranging effects on G
proteins and G-protein-coupled receptors (Freissmuth et al.
1999). Nonetheless in the context of S1P receptors, suramin
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has been shown to be effective in inhibiting signaling through
S1P3R but ineffective in inhibiting signaling via S1P1R or
S1P2R into the millimolar range (Ancellin and Hla 1999).
Another indication that S1P is signaling through an additional
receptor in amacrine cells comes from data in Fig. 10, B and D.
The distinctive Ca2⫹ response patterns with respect to store
release versus influx produced in the presence of each inhibitor
(PTX or suramin) provide additional physiological evidence
for signaling through both S1P1R and S1P3R in amacrine
cells.
Intriguingly, there is evidence for an obligate collaboration
between S1P1R and S1P3R in some signaling pathways.
S1P1R and S1P3R are co-expressed and are both required for
endothelial cell proliferation (Kimura et al. 2000), migration
(Kimura et al. 2000; Paik et al. 2001), and morphogenesis (Lee
et al. 1999). Especially relevant to our results, S1P1R has been
shown to actually suppress Ca2⫹ signaling unless it is coexpressed with S1P3R specifically (Meyer zu Heringdorf et al.
2003b). Interestingly, heterodimers of S1P1R and S1P3R have
been detected in expressions studies (Van Brocklyn et al.
2002), so it may be that dimerization is a requirement for
interactions between these receptors.
Much debate exists as to whether S1P couples to release of
Ca2⫹ from internal stores through activation of IP3Rs on the
endoplasmic reticulum. In Swiss 3T3 fibroblasts, S1P stimulated an increase in cellular IP3 levels, but the S1P-induced
Ca2⫹ increase was unaffected by blocking IP3 receptors with
heparin (Mattie et al. 1994). The IP3R-independent but S1Pdependent Ca2⫹ increase has been observed in other cell types
as well (Ghosh et al. 1994; Im et al. 2005; Spiegel and Milstein
2002; Tornquist et al. 1997). In the present study, we observed
S1P activation of a PLC-dependent but IP3R-independent current.
In addition to activation of receptors at the plasma membrane, S1P can also signal internally. There is good evidence
that S1P can act as a Ca2⫹ influx factor (Borges et al. 2008;
Igataki and Hauser 2003). A potentially relevant intracellular
interaction has been shown between S1P and TRPC5 (Xu et al.
2006). It was demonstrated that intracellular S1P acts directly
as an internal ligand for the natively expressed TRPC1-5
heteromultimers in the plasma membrane of smooth muscle
cells. Furthermore, this interaction was shown to lead to
channel activity and Ca2⫹ influx. These observations fit well
with the Ca2⫹/calmodulin-dependence of SphK (Hla et al.
1999), and the idea that receptor-dependent Ca2⫹ elevations
could activate SphK, and produce S1P that triggers gating of a
Ca2⫹ influx channel. An important link was established when
it was demonstrated that Ca2⫹ influx was eliminated in mast
cells from SphK2 knockout mice (Olivera et al. 2007). Interestingly, it is emerging that it may not be the activity of SphK
that is Ca2⫹/calmodulin sensitive but the localization. In expression systems, a Ca2⫹-dependent translocation of SphK1 to
the plasma membrane leads to generation of S1P (Alemany
et al. 2000, 2001; Sutherland et al. 2006). Although we have
not yet confirmed the involvement of TRPC channels specifically, the effects of inhibiting SphK on the receptor-mediated
Ca2⫹ elevations provides further evidence that internally generated S1P can gate a Ca2⫹ influx channel in amacrine cells.
Is S1P activating store-operated Ca2⫹ entry (SOCE) in
amacrine cells? SOCE is defined as the influx of Ca2⫹ that is
dependent on depletion of Ca2⫹ from internal stores (for
J Neurophysiol • VOL
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review, see Smyth et al. 2006). A corollary of this definition is
that the activation of receptors is not involved. The expression
of SOCE is variable among neurons (for review, see Putney
2003), but there is strong evidence that SOCE exists in amacrine cell dendrites (Borges et al. 2008). Our current recordings
are from the whole cell and our fluorescent measurements have
been made from cell bodies but there are some consistencies
with SOCE in the results reported here. First, we show that the
S1P-dependent Ca2⫹ elevation typically involves release of
Ca2⫹ from stores and that the S1P-dependent current does not
precede the elevation of cytosolic Ca2⫹. We also show that the
S1P-dependent current is not dependent on the activity of the
IP3 receptor, and we demonstrate that both the S1P-dependent
current and the S1P-dependent Ca2⫹ elevations are sensitive to
M concentrations of lanthanides. Nonetheless, our results fail
a primary test of SOCE: independence from receptor activation. The inhibitory effects of PTX, the requirement for PLC
activity, and the ability for SEW2871 to partially substitute for
S1P all point to the involvement of a receptor (or receptors) in
the mediation of the effects of S1P reported here. Perhaps the
answer lies somewhere in the middle in that receptor-mediated
S1P signaling might somehow co-opt the SOCE mechanism
expressed by amacrine cells.
The evidence presented in this study points to S1P activation
of a Ca2⫹-permeable cation channel at the plasma membrane.
One potential function of this sort of channel is to mediate
localized receptor-dependent Ca2⫹ entry and allow for neurotransmitter release without the involvement of voltage-gated
Ca2⫹ channels. Indeed Chavez et al. (2006) demonstrated
GABAergic feedback in amacrine cells through activation of
postsynaptic ionotropic glutamate receptors and Ca2⫹-induced-Ca2⫹ release. It has also been demonstrated that release
from internal stores can elicit GABA release in cultured amacrine cells (Warrier et al. 2005). It will be important to
determine whether S1P, through the complex lipid signaling
pathway proposed in this study, is capable of mediating synaptic signaling in the inner retina.
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